Olubukola Ayodele: Cancer doesn’t discriminate, but healthcare systems do
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a post on LinkedIn:
“Here’s my 2024 LinkedIn Rewind, by Coauthor.studio:
Cancer doesn’t discriminate, but healthcare systems do.
In 2024, I discovered that transforming oncology means dismantling invisible barriers, one research project, one conversation at a time.
This year wasn’t about my achievements – it was about amplifying voices historically silenced in medical research and care.
When we convened the Cancer Health Disparities Day at the House of Commons, we weren’t just hosting a meeting; we were rebuilding the foundations of equitable healthcare.
Key moments that redefined what’s possible:
Leading the Breast Cancer Unit at University Hospitals of Leicester, we expanded clinical trials to include more diverse patient populations. Our research isn’t just about data – it’s about ensuring every patient sees themselves represented in treatment pathways.
Launching our community engagement programs in Leicester revealed something profound: Healthcare literacy is a powerful form of empowerment. By creating safe spaces for South Asian and African communities to discuss cancer, we’re transforming fear into knowledge.
Three posts that captured our collective journey:
Cancer Health Disparities at the House of Commons Proving that institutional change starts with courageous conversations.
Genomics and Diversity in Cancer Clinical Trials Challenging the systemic biases in medical research.
UHL Educator Awards Recognition Recognizing that mentorship is our most powerful tool for systemic change.
2025 isn’t just another year – it’s an opportunity to continue building a more just healthcare ecosystem. Our breast cancer clinical trials will expand, our global partnerships will deepen, and we’ll keep pushing the boundaries of what equitable care means.
To every patient who has shared their story, every researcher challenging the status quo, every community leader creating spaces for dialogue – this work continues because of you.
Get your 2024 LinkedIn Rewind. Go to coauthor.studio.”
Dr. Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, specializing in breast and genitourinary malignancies, including germ cell tumors. She is also an honorary Senior Lecturer at the University of Leicester and heads the Breast Cancer Clinical Trials Unit at the Leicester Cancer Research Centre.
Dr. Ayodele’s work includes numerous publications, clinical trials, and collaborative research projects on molecular drivers and biomarkers in breast cancer. She is a member of ASCO, ESMO, ACP and UKBCG.
More posts featuring Olubukola Ayodele.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023